PF-04217329

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-04217329, covering 2021-04-30 to 2021-05-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 [Phase 2]